{"id":"https://openalex.org/W3025967965","doi":"https://doi.org/10.2217/fon-2019-0821","title":"Cost\u2013effectiveness analysis of nivolumab in the second-line treatment for advanced esophageal squamous cell carcinoma","display_name":"Cost\u2013effectiveness analysis of nivolumab in the second-line treatment for advanced esophageal squamous cell carcinoma","publication_year":2020,"publication_date":"2020-05-14","ids":{"openalex":"https://openalex.org/W3025967965","doi":"https://doi.org/10.2217/fon-2019-0821","mag":"3025967965","pmid":"https://pubmed.ncbi.nlm.nih.gov/32407173"},"language":"en","primary_location":{"id":"doi:10.2217/fon-2019-0821","doi":"https://doi.org/10.2217/fon-2019-0821","is_oa":false,"landing_page_url":"https://doi.org/10.2217/fon-2019-0821","pdf_url":null,"source":{"id":"https://openalex.org/S174572715","display_name":"Future Oncology","issn_l":"1479-6694","issn":["1479-6694","1744-8301"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103541492","display_name":"Peng-Fei Zhang","orcid":"https://orcid.org/0009-0009-4972-6412","observed_orcids":["https://orcid.org/0009-0009-4972-6412"]},"institutions":[{"id":"https://openalex.org/I24185976","display_name":"Sichuan University","ror":"https://ror.org/011ashp19","country_code":"CN","type":"education","lineage":["https://openalex.org/I24185976"]},{"id":"https://openalex.org/I2800091995","display_name":"West China Medical Center of Sichuan University","ror":"https://ror.org/040nggs60","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I24185976","https://openalex.org/I2800091995"]},{"id":"https://openalex.org/I4210089761","display_name":"West China Hospital of Sichuan University","ror":"https://ror.org/007mrxy13","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210089761"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Peng-Fei Zhang","raw_affiliation_strings":["Department of Medical Oncology, Cancer Center, West China Hospital,Sichuan University, Chengdu, PR China","West China Biomedical Big Data Center, West China Hospital/West China School of Medicine,Sichuan University, Chengdu, PR China","Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, PR ChinaWest China Biomedical Big Data Center, West China Hospital/West China School of Medicine, Sichuan University, Chengdu, PR China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Cancer Center, West China Hospital,Sichuan University, Chengdu, PR China","institution_ids":["https://openalex.org/I24185976","https://openalex.org/I4210089761"]},{"raw_affiliation_string":"West China Biomedical Big Data Center, West China Hospital/West China School of Medicine,Sichuan University, Chengdu, PR China","institution_ids":["https://openalex.org/I24185976","https://openalex.org/I2800091995","https://openalex.org/I4210089761"]},{"raw_affiliation_string":"Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, PR ChinaWest China Biomedical Big Data Center, West China Hospital/West China School of Medicine, Sichuan University, Chengdu, PR China","institution_ids":["https://openalex.org/I24185976","https://openalex.org/I2800091995","https://openalex.org/I4210089761"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Dan Xie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I24185976","display_name":"Sichuan University","ror":"https://ror.org/011ashp19","country_code":"CN","type":"education","lineage":["https://openalex.org/I24185976"]},{"id":"https://openalex.org/I4210089228","display_name":"West China Second University Hospital of Sichuan University","ror":"https://ror.org/00726et14","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210089228"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Dan Xie","raw_affiliation_strings":["Prenatal Diagnosis Center, Department of Obstetrics & Gynecology,West China Second University Hospital, Sichuan University, Chengdu, PR China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Prenatal Diagnosis Center, Department of Obstetrics & Gynecology,West China Second University Hospital, Sichuan University, Chengdu, PR China","institution_ids":["https://openalex.org/I24185976","https://openalex.org/I4210089228"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5066972913","display_name":"Qiu Li","orcid":"https://orcid.org/0000-0002-5299-9050","observed_orcids":["https://orcid.org/0000-0002-5299-9050"]},"institutions":[{"id":"https://openalex.org/I24185976","display_name":"Sichuan University","ror":"https://ror.org/011ashp19","country_code":"CN","type":"education","lineage":["https://openalex.org/I24185976"]},{"id":"https://openalex.org/I2800091995","display_name":"West China Medical Center of Sichuan University","ror":"https://ror.org/040nggs60","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I24185976","https://openalex.org/I2800091995"]},{"id":"https://openalex.org/I4210089761","display_name":"West China Hospital of Sichuan University","ror":"https://ror.org/007mrxy13","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210089761"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Qiu Li","raw_affiliation_strings":["Department of Medical Oncology, Cancer Center, West China Hospital,Sichuan University, Chengdu, PR China","West China Biomedical Big Data Center, West China Hospital/West China School of Medicine,Sichuan University, Chengdu, PR China","Fax: +86 28 8542 3609"],"raw_orcid":"https://orcid.org/0000-0002-5299-9050","affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Cancer Center, West China Hospital,Sichuan University, Chengdu, PR China","institution_ids":["https://openalex.org/I24185976","https://openalex.org/I4210089761"]},{"raw_affiliation_string":"West China Biomedical Big Data Center, West China Hospital/West China School of Medicine,Sichuan University, Chengdu, PR China","institution_ids":["https://openalex.org/I24185976","https://openalex.org/I2800091995","https://openalex.org/I4210089761"]},{"raw_affiliation_string":"Fax: +86 28 8542 3609","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":7.8531,"has_fulltext":false,"cited_by_count":55,"citation_normalized_percentile":{"value":0.97416524,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"16","issue":"17","first_page":"1189","last_page":"1198"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.8726000189781189,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.8726000189781189,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10619","display_name":"Esophageal Cancer Research and Treatment","score":0.09700000286102295,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.013299999758601189,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":1.0},{"id":"https://openalex.org/keywords/esophageal-squamous-cell-carcinoma","display_name":"esophageal squamous cell carcinoma","score":0.9860000014305115},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.9139999747276306},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.9269999861717224},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.7459999918937683},{"id":"https://openalex.org/keywords/chemotherapy","display_name":"chemotherapy","score":0.8730000257492065},{"id":"https://openalex.org/keywords/quality-adjusted-life-years","display_name":"quality-adjusted life years","score":0.8339999914169312},{"id":"https://openalex.org/keywords/incremental-cost-effectiveness-ratio","display_name":"incremental cost-effectiveness ratio","score":0.8759999871253967},{"id":"https://openalex.org/keywords/markov-model","display_name":"Markov model","score":0.6330000162124634},{"id":"https://openalex.org/keywords/weibull-survival-model","display_name":"Weibull survival model","score":0.7730000019073486}],"concepts":[{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.9091885089874268},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8957616090774536},{"id":"https://openalex.org/C2994415158","wikidata":"https://www.wikidata.org/wiki/Q372701","display_name":"Esophageal squamous cell carcinoma","level":3,"score":0.6740676164627075},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6490600109100342},{"id":"https://openalex.org/C3019258254","wikidata":"https://www.wikidata.org/wiki/Q1423317","display_name":"Second line","level":3,"score":0.5992366671562195},{"id":"https://openalex.org/C2777546739","wikidata":"https://www.wikidata.org/wiki/Q33525","display_name":"Carcinoma","level":2,"score":0.4775612950325012},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47621259093284607},{"id":"https://openalex.org/C3019992690","wikidata":"https://www.wikidata.org/wiki/Q92767510","display_name":"Basal cell","level":2,"score":0.44566476345062256},{"id":"https://openalex.org/C2993493390","wikidata":"https://www.wikidata.org/wiki/Q5453208","display_name":"First line","level":2,"score":0.36307597160339355},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.30950838327407837},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.14716461300849915}],"mesh":[{"descriptor_ui":"D000066491","descriptor_name":"Clinical Decision-Making","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000077277","descriptor_name":"Esophageal Squamous Cell Carcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000077277","descriptor_name":"Esophageal Squamous Cell Carcinoma","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D000077277","descriptor_name":"Esophageal Squamous Cell Carcinoma","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D000077277","descriptor_name":"Esophageal Squamous Cell Carcinoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D000077594","descriptor_name":"Nivolumab","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000077594","descriptor_name":"Nivolumab","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000077594","descriptor_name":"Nivolumab","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000082082","descriptor_name":"Immune Checkpoint Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000082082","descriptor_name":"Immune Checkpoint Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000082082","descriptor_name":"Immune Checkpoint Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004938","descriptor_name":"Esophageal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004938","descriptor_name":"Esophageal Neoplasms","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D004938","descriptor_name":"Esophageal Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D004938","descriptor_name":"Esophageal Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008390","descriptor_name":"Markov Chains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017048","descriptor_name":"Health Care Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019057","descriptor_name":"Quality-Adjusted Life Years","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019233","descriptor_name":"Retreatment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019468","descriptor_name":"Disease Management","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2217/fon-2019-0821","doi":"https://doi.org/10.2217/fon-2019-0821","is_oa":false,"landing_page_url":"https://doi.org/10.2217/fon-2019-0821","pdf_url":null,"source":{"id":"https://openalex.org/S174572715","display_name":"Future Oncology","issn_l":"1479-6694","issn":["1479-6694","1744-8301"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future Oncology","raw_type":"journal-article"},{"id":"pmid:32407173","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32407173","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future oncology (London, England)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320321001","display_name":"National Natural Science Foundation of China","ror":"https://ror.org/01h0zpd94"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W1958962196","https://openalex.org/W1968053975","https://openalex.org/W1983579026","https://openalex.org/W2032689844","https://openalex.org/W2044720517","https://openalex.org/W2047783753","https://openalex.org/W2104347254","https://openalex.org/W2137210918","https://openalex.org/W2138098788","https://openalex.org/W2143163879","https://openalex.org/W2156353875","https://openalex.org/W2339262930","https://openalex.org/W2418354692","https://openalex.org/W2523998306","https://openalex.org/W2563797543","https://openalex.org/W2567353654","https://openalex.org/W2591102292","https://openalex.org/W2596604644","https://openalex.org/W2607038984","https://openalex.org/W2749884966","https://openalex.org/W2768511747","https://openalex.org/W2768885730","https://openalex.org/W2787981425","https://openalex.org/W2792430821","https://openalex.org/W2793938337","https://openalex.org/W2889004312","https://openalex.org/W2889646458","https://openalex.org/W2900705321","https://openalex.org/W2921677770","https://openalex.org/W2976652879","https://openalex.org/W4211048478","https://openalex.org/W4230938913"],"related_works":["https://openalex.org/W4283709094","https://openalex.org/W4286717279","https://openalex.org/W4296210975","https://openalex.org/W3160851362","https://openalex.org/W4380150462","https://openalex.org/W3168071637","https://openalex.org/W4378952738","https://openalex.org/W4386707523","https://openalex.org/W4212894532","https://openalex.org/W4392188848"],"abstract_inverted_index":{"Background:":[0],"To":[1],"investigate":[2],"the":[3,10,26,29,41,50,64,67,71,107],"cost\u2013effectiveness":[4,90],"of":[5,49,76,92,109],"nivolumab":[6,51,77],"versus":[7,78],"chemotherapy":[8,53,79,105],"in":[9,28,66,87],"second-line":[11],"treatment":[12,101],"for":[13],"advanced":[14],"esophageal":[15],"squamous":[16],"cell":[17],"carcinoma.":[18],"Materials":[19],"&":[20],"methods:":[21],"A":[22],"Markov":[23],"model":[24,36],"reflecting":[25],"patients":[27],"ATTRACTION-3":[30],"trial":[31],"was":[32,37],"established.":[33],"Weibull":[34],"survival":[35,44,47],"employed":[38],"to":[39,62],"fit":[40],"Kaplan\u2013Meier":[42],"progression-free":[43],"and":[45,52,58,74,84],"overall":[46],"probabilities":[48],"strategy,":[54],"respectively.":[55],"Meanwhile,":[56],"one-way":[57],"PSA":[59],"were":[60,80],"performed":[61],"test":[63],"uncertainty":[65],"model.":[68],"Results:":[69],"Overall,":[70],"incremental":[72,89],"effectiveness":[73],"cost":[75],"0.107":[81],"quality-adjusted":[82],"life-years":[83],"$14,627.90,":[85],"resulting":[86],"an":[88],"ratio":[91],"$136,709.35/quality-adjusted":[93],"life-year.":[94],"Conclusion:":[95],"Nivolumab":[96],"is":[97],"not":[98],"a":[99],"cost-effective":[100],"option":[102],"compared":[103],"with":[104],"from":[106],"perspective":[108],"Chinese":[110],"society.":[111]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":10},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":25},{"year":2021,"cited_by_count":5}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2020-05-21T00:00:00"}